Clazosentan Affects Temporal Profile of Endothelin-A Expression in Macro- and Microcirculation after Subarachnoid Hemorrhage
Subarachnoid hemorrhage is a life-threatening cerebrovascular event, and cerebral vasospasm remains a major cause of poor neurological outcomes. Clazosentan, an endothelin-A receptor antagonist, has been recently approved in Japan to reduce post-subarachnoid hemorrhage vasospasm; however, recurrent...
保存先:
| 主要な著者: | , , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
The Japan Neurosurgical Society
2026-02-01
|
| シリーズ: | Neurologia Medico-Chirurgica |
| 主題: | |
| オンライン･アクセス: | https://www.jstage.jst.go.jp/article/nmc/66/2/66_2025-0185/_pdf/-char/en |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|